Common Name

Biopterin Description

Biopterin concentrations in cerebrospinal fluid from patients with Parkinsons disease, in which the nigrostriatal dopamine neurons degenerate, are lower than those from age-matched older controls. In hereditary progressive dystonia/DOPA-responsive dystonia, which is a dopamine deficiency caused by mutations in GTP cyclohydrolase I without neuronal cell death (Segawas disease), neopterin and biopterin in cerebrospinal fluid decrease in parallel owing to the decreased activity in GTP cyclohydrolase I. GTP cyclohydrolase I (EC 3.5.4.16) is an enzyme that is part of the folate and biopterin biosynthesis pathways. It is responsible for the hydrolysis of guanosine triphosphate (GTP) to form 7,8-dihydroneopterin 3-triphosphate. (Pteridines (1999), 10(1), 5-13.) Lowered levels of urinary biopterin concomitant with elevated serum phenylalanine concentration occur in a variant type of hyperphenylalaninemia caused by a deficiency of tetrahydrobiopterin (BH4), the obligatory cofactor for phenylalanine hydroxylase. The most frequent form of this cofactor deficiency is due to lack of 6-pyruvoyl-tetrahydropterin synthase (PTPS) activity, the second enzyme in the biosynthetic pathway for BH4. (PMID 8178819 ) The hepatic phenylalanine hydroxylating system consists of 3 essential components, phenylalanine hydroxylase, dihydropteridine reductase, and the nonprotein coenzyme, tetrahydrobiopterin. The reductase and the pterin coenzyme are also essential components of the tyrosine and tryptophan hydroxylating systems. There are 3 distinct forms of phenylketonuria or hyperphenylalaninemia, each caused by lack of 1 of these essential components. The variant forms of the disease that are caused by the lack of dihydropteridine reductase or tetrahydrobiopterin are characterized by severe neurol. deterioration, impaired functioning of tyrosine and tryptophan hydroxylases, and the reslitant deficiency of tyrosine- and tryptophan-derived monoamine neurotransmitters in brain. (PMID 3930837 ). Structure

Synonyms

Value Source (-)-BiopterinChEBI (1'r,1's) BiopterinHMDB 2-amino-6-(L-erythro-1,2-Dihydroxypropyl)-4(3H)-pteridinoneHMDB 6-BiopterinHMDB L-BiopterinHMDB L-erythro-BiopterinHMDB Pterin H b2HMDB [S-(R*,s*)]-2-amino-6-(1,2-dihydroxypropyl)-4(1H)-pteridinoneHMDB OrinapterinMeSH DictyopterinMeSH 2-amino-6-(1,2-Dihydroxypropyl)-4(1H)-pteridinoneMeSH

Chemical Formlia

C9H11N5O3 Average Molecliar Weight

237.2153 Monoisotopic Molecliar Weight

237.086189243 IUPAC Name

2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1,4-dihydropteridin-4-one Traditional Name

2-amino-6-[(1R,2S)-1,2-dihydroxypropyl]-1H-pteridin-4-one CAS Registry Number

22150-76-1 SMILES

C[C@H](O)[C@H](O)C1=NC2=C(NC(N)=NC2=O)N=C1

InChI Identifier

InChI=1S/C9H11N5O3/c1-3(15)6(16)4-2-11-7-5(12-4)8(17)14-9(10)13-7/h2-3,6,15-16H,1H3,(H3,10,11,13,14,17)/t3-,6-/m0/s1

InChI Key

LHQIJBMDNUYRAM-DZSWIPIPSA-N Chemical Taxonomy Description

This compound belongs to the class of chemical entities known as biopterins and derivatives. These are coenzymes containing a 2-amino-pteridine-4-one derivative. They are mainly synthesized in several parts of the body, including the pineal gland. Kingdom

Chemical entities Super Class

Organic compounds Class

Organoheterocyclic compounds Sub Class

Pteridines and derivatives Direct Parent

Biopterins and derivatives Alternative Parents

  • Pyrimidones
  • Aminopyrimidines and derivatives
  • Pyrazines
  • Primary aromatic amines
  • Vinylogous amides
  • Heteroaromatic compounds
  • Secondary alcohols
  • 1,2-diols
  • Azacyclic compounds
  • Organopnictogen compounds
  • Organic oxides
  • Hydrocarbon derivatives
  • Aromatic alcohols
  • Substituents

  • Biopterin
  • Aminopyrimidine
  • Pyrimidone
  • Primary aromatic amine
  • Pyrazine
  • Pyrimidine
  • Vinylogous amide
  • Heteroaromatic compound
  • Secondary alcohol
  • 1,2-diol
  • Azacycle
  • Organic oxide
  • Amine
  • Alcohol
  • Organopnictogen compound
  • Primary amine
  • Organooxygen compound
  • Organonitrogen compound
  • Organic oxygen compound
  • Organic nitrogen compound
  • Aromatic alcohol
  • Hydrocarbon derivative
  • Aromatic heteropolycyclic compound
  • Molecliar Framework

    Aromatic heteropolycyclic compounds External Descriptors

  • biopterin (CHEBI:63931 )
  • Ontology Status

    Detected and Quantified Origin

  • Endogenous
  • Biofunction

  • Component of Phenylalanine, tyrosine and tryptophan biosynthesis
  • Component of Tyrosine metabolism
  • Enzyme co-factor
  • Application

    Not Available Cellliar locations

  • Cytoplasm
  • Physical Properties State

    Solid Experimental Properties

    Property Value Reference Melting PointNot AvailableNot Available Boiling PointNot AvailableNot Available Water Solubility0.7 mg/mLNot Available LogPNot AvailableNot Available

    Predicted Properties

    Property Value Source Water Solubility4.06 mg/mLALOGPS logP-0.87ALOGPS logP-1.2ChemAxon logS-1.8ALOGPS pKa (Strongest Acidic)7.6ChemAxon pKa (Strongest Basic)-1.3ChemAxon Physiological Charge0ChemAxon Hydrogen Acceptor Count8ChemAxon Hydrogen Donor Count4ChemAxon Polar Surface Area133.72 Å2ChemAxon Rotatable Bond Count2ChemAxon Refractivity58.13 m3·mol-1ChemAxon Polarizability22.41 Å3ChemAxon Number of Rings2ChemAxon Bioavailability1ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon

    Spectra Spectra

    Spectrum Type Description Splash Key GC-MS

    GC-MS Spectrum – GC-EI-TOF (Pegasus III TOF-MS system, Leco; GC 6890, Agilent Technologies)splash10-0aos-1922500000-07177d5a450dbf7c637aView in MoNA LC-MS/MS

    LC-MS/MS Spectrum – Quattro_QQQ 10V, Positive (Annotated)splash10-000i-0190000000-cea25aa8258af5c9e837View in MoNA LC-MS/MS

    LC-MS/MS Spectrum – Quattro_QQQ 25V, Positive (Annotated)splash10-004i-0900000000-32102578ef16c3df8f17View in MoNA LC-MS/MS

    LC-MS/MS Spectrum – Quattro_QQQ 40V, Positive (Annotated)splash10-0a5c-5900000000-441b149b7ee5432cdac3View in MoNA 1D NMR

    1H NMR SpectrumNot Available 2D NMR

    [1H,13C] 2D NMR SpectrumNot Available

    Biological Properties Cellliar Locations

  • Cytoplasm
  • Biofluid Locations

  • Blood
  • Cellliar Cytoplasm
  • Cerebrospinal Fluid (CSF)
  • Urine
  • Tissue Location

  • Brain
  • Epidermis
  • Fibroblasts
  • Liver
  • Prostate
  • Pathways

    Not Available Normal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details BloodDetected and Quantified0.017 +/- 0.0025 uMAdlit (>18 years old)BothNormal

  • Geigy Scientific …
  • details Cellliar CytoplasmDetected and Quantified0.033 +/- 0.0073 uMAdlit (>18 years old)Not SpecifiedNormal

  • Geigy Scientific …
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0.026 – 0.052 uMNewborn (0-30 days old)Not SpecifiedNormal

  • 15652629
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0.021 – 0.038 uMInfant (0-1 year old)Not SpecifiedNormal

  • 15652629
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0.0132 +/- 0.0005 uMNot SpecifiedNot SpecifiedNormal

  • 7669428
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0.01-0.042 uMChildren (1-13 years old)MaleNormal

  • 18502672
  • details UrineDetected and Quantified0.24 +/- 0.07 umol/mmol creatinineAdlit (>18 years old)MaleNormal

  • Geigy Scientific …
  • details UrineDetected and Quantified0.32 +/- 0.13 umol/mmol creatinineAdlit (>18 years old)FemaleNormal

  • Geigy Scientific …
  • details UrineDetected and Quantified0.48 +/- 0.17 umol/mmol creatinineChildren (1-13 years old)BothNormal

  • Geigy Scientific …
  • details UrineDetected and Quantified0.13 +/- 0.084 umol/mmol creatinineNewborn (0-30 days old)BothNormal

  • 3939585
  • details UrineDetected and Quantified0.3 +/- 0.14 umol/mmol creatinineChildren (1-13 years old)BothNormal

  • 3939585
  • details

    Abnormal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details Cerebrospinal Fluid (CSF)Detected and Quantified0.0376 (0.0281-0.0471) uMChildren (1-13 years old)Malesepiapterin reductase deficiency

  • 18502672
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0.0085 +/- 0.0003 uMNot SpecifiedNot Specifiedidiopathic parkinsonisam

  • 7669428
  • details Cerebrospinal Fluid (CSF)Detected and Quantified0.0142 +/- 0.0012 uMNot SpecifiedNot Specifieddopa-nonresponsive dystonia

  • 7669428
  • details Cerebrospinal Fluid (CSF)Detected and Quantified20.6 (19.2 – 22.0) uMAdlit (>18 years old)Not SpecifiedSegawa Syndrome

  • 16289769
  • details

    Associated Disorders and Diseases Disease References

    Segawa Syndrome

    1. Furuya H, Murai H, Takasugi K, Ohyagi Y, Urano F, Kishi T, Ichinose H, Kira J: A case of late-onset Segawa syndrome (autosomal dominant dopa-responsive dystonia) with a novel mutation of the GTP-cyclohydrase I (GCH1) gene. Clin Neurol Neurosurg. 2006 Dec;108(8):784-6. Epub 2005 Nov 14. [PubMed:16289769 ]

    Associated OMIM IDs

  • 128230 (Segawa Syndrome)
  • External Links DrugBank ID

    Not Available DrugBank Metabolite ID

    Not Available Phenol Explorer Compound ID

    Not Available Phenol Explorer Metabolite ID

    Not Available FoodDB ID

    FDB022060 KNApSAcK ID

    Not Available Chemspider ID

    392795 KEGG Compound ID

    C06313 BioCyc ID

    BIOPTERIN BiGG ID

    Not Available Wikipedia Link

    Biopterin NuGOwiki Link

    HMDB00468 Metagene Link

    HMDB00468 METLIN ID

    247 PubChem Compound

    445040 PDB ID

    1B66 ChEBI ID

    63931

    Product: E7820

    References Synthesis Reference Mori, Kenji; Kikuchi, Haruhiko. Synthesis of (-)-biopterin. Liebigs Annalen der Chemie (1989), (10), 963-7. Material Safety Data Sheet (MSDS) Not Available General References
    1. Thony B, Leimbacher W, Blau N, Harvie A, Heizmann CW: Hyperphenylalaninemia due to defects in tetrahydrobiopterin metabolism: molecular characterization of mutations in 6-pyruvoyl-tetrahydropterin synthase. Am J Hum Genet. 1994 May;54(5):782-92. [PubMed:8178819 ]
    2. Bonafe L, Thony B, Penzien JM, Czarnecki B, Blau N: Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet. 2001 Aug;69(2):269-77. Epub 2001 Jul 6. [PubMed:11443547 ]
    3. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
    4. Fiege B, Ballhausen D, Kierat L, Leimbacher W, Goriounov D, Schircks B, Thony B, Blau N: Plasma tetrahydrobiopterin and its pharmacokinetic following oral administration. Mol Genet Metab. 2004 Jan;81(1):45-51. [PubMed:14728990 ]
    5. Friedland RP, Koss E, Haxby JV, Grady CL, Luxenberg J, Schapiro MB, Kaye J: NIH conference. Alzheimer disease: clinical and biological heterogeneity. Ann Intern Med. 1988 Aug 15;109(4):298-311. [PubMed:2969203 ]
    6. Snyderman SE, Sansaricq C, Pulmones MT: Successful long term therapy of biopterin deficiency. J Inherit Metab Dis. 1987;10(3):260-6. [PubMed:3123784 ]
    7. Nagatsu T, Yamaguchi T, Kato T, Sugimoto T, Matsuura S, Akino M, Nagatsu I, Iizuka R, Narabayashi H: Biopterin in human brain and urine from controls and parkinsonian patients: application of a new radioimmunoassay. Clin Chim Acta. 1981 Feb 5;109(3):305-11. [PubMed:6112078 ]
    8. Katoh S, Sueoka T, Matsuura S, Sugimoto T: Biopterin and neopterin in human saliva. Life Sci. 1989;45(26):2561-8. [PubMed:2615555 ]
    9. Ichinose H, Ohye T, Shinotoh H, Arai K, Yamazaki S, Mizuta E, Kuno S, Nagatsu T: Biopterin metabolism in patients with malignant syndrome. Parkinsonism Relat Disord. 2003 Apr;9 Suppl 1:S11-4. [PubMed:12735910 ]
    10. Zurfluh MR, Giovannini M, Fiori L, Fiege B, Gokdemir Y, Baykal T, Kierat L, Gartner KH, Thony B, Blau N: Screening for tetrahydrobiopterin deficiencies using dried blood spots on filter paper. Mol Genet Metab. 2005 Dec;86 Suppl 1:S96-103. Epub 2005 Nov 7. [PubMed:16275037 ]
    11. Ogiwara S, Kiuchi K, Nagatsu T, Teradaira R, Nagatsu I, Fujita K, Sugimoto T: Highly sensitive, specific enzyme-linked immunosorbent assay of neopterin and biopterin in biological samples. Clin Chem. 1992 Oct;38(10):1954-8. [PubMed:1394977 ]
    12. Hirata Y, Sawada M, Minami M, Arai H, Iizuka R, Nagatsu T: Tyrosine hydroxylase, tryptophan hydroxylase, biopterin, and neopterin in the brain of anorexia nervosa. J Neural Transm Gen Sect. 1990;80(2):145-50. [PubMed:1969283 ]
    13. Dhondt JL, Tilmont P, Ringel J, Farriaux JP: Pterins analysis in amniotic fluid for the prenatal diagnosis of GTP cyclohydrolase deficiency. J Inherit Metab Dis. 1990;13(6):879-82. [PubMed:2079836 ]
    14. Furukawa Y, Kapatos G, Haycock JW, Worsley J, Wong H, Kish SJ, Nygaard TG: Brain biopterin and tyrosine hydroxylase in asymptomatic dopa-responsive dystonia. Ann Neurol. 2002 May;51(5):637-41. [PubMed:12112113 ]
    15. Bonafe L, Thony B, Leimbacher W, Kierat L, Blau N: Diagnosis of dopa-responsive dystonia and other tetrahydrobiopterin disorders by the study of biopterin metabolism in fibroblasts. Clin Chem. 2001 Mar;47(3):477-85. [PubMed:11238300 ]
    16. Slazyk WE, Spierto FW: Liquid-chromatographic measurement of biopterin and neopterin in serum and urine. Clin Chem. 1990 Jul;36(7):1364-8. [PubMed:2372953 ]
    17. Dhondt JL, Hayte JM, Forzy G, Delcroix M, Farriaux JP: Unconjugated pteridines in amniotic fluid during gestation. Clin Chim Acta. 1986 Dec 30;161(3):269-73. [PubMed:3802534 ]
    18. Iizuka T, Sasaki M, Oishi K, Uemura S, Koike M, Minatogawa Y: Nitric oxide may trigger lactation in humans. J Pediatr. 1997 Dec;131(6):839-43. [PubMed:9427887 ]
    19. Zoghbi HY, Milstien S, Butler IJ, Smith EO, Kaufman S, Glaze DG, Percy AK: Cerebrospinal fluid biogenic amines and biopterin in Rett syndrome. Ann Neurol. 1989 Jan;25(1):56-60. [PubMed:2913929 ]
    20. Kaufman S: Hyperphenylalaninaemia caused by defects in biopterin metabolism. J Inherit Metab Dis. 1985;8 Suppl 1:20-7. [PubMed:3930837 ]
    21. (). Nagatsu T, Ichinose H, Mogi M, Togari A (1999) Neopterin and cytokines in hereditary dystonia and Parkinson’s disease. Pteridines 10: 5–13.. .

    PMID: 2160275